{rfName}
Co

Indexed in

License and use

Citations

Altmetrics

Grant support

This study was supported by the Cooperative Research Thematic Network grants RD12/0036/0058 and RD12/0036/0046 of the Red de Cancer (Cancer Network of Excellence); Instituto de Salud Carlos III, Spain, Instituto de Salud Carlos III/Subdireccion General de Investigacion Sanitaria part-financed by the European Regional Development Fund (FIS: PI12/01761; PI12/02311; PI13/01469; PI14/01867, G03/136; Sara Borrell: CD13/00340); Asociacion Espanola Contra el Cancer (GCB120981SAN) and FEDER.

Impact on the Sustainable Development Goals (SDGs)

Analysis of institutional authors

De Oteyza JpAuthor

Share

March 11, 2019
Publications
>
Correction
No

Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role

Publicated to:Leukemia. 33 (4): 1056-1056 - 2019-04-01 33(4), DOI: 10.1038/s41375-019-0408-x

Authors: Rodriguez-Otero, Paula; Victoria Mateos, Maria; Martinez-Lopez, Joaquin; Martin-Calvo, Nerea; Hernandez, Miguel-Teodoro; Ocio, Enrique M; Rosinol, Laura; Martinez, Rafael; Teruel, Ana-Isabel; Gutierrez, Norma C; Bargay, Joan; Bengoechea, Enrique; Gonzalez, Yolanda; Perez de Oteyza, Jaime; Gironella, Mercedes; Encinas, Cristina; Martin, Jesus; Cabrera, Carmen; Palomera, Luis; de Arriba, Felipe; Teresa Cedena, Maria; Paiva, Bruno; Puig, Noemi; Oriol, Albert; Blade, Joan; Jose Lahuerta, Juan; San Miguel, Jesus F

Affiliations

Clin Univ Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain - Author
Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain - Author
Complejo Asistencial Univ Salamanca, Inst Invest Biomed Salamanca, Salamanca, Spain - Author
Complejo Asistencial Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain - Author
Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Insitut Catala Oncol, Barcelona, Spain - Author
Hosp Clin I Prov, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain - Author
Hosp Clin San Carlos, Madrid, Spain - Author
Hosp Clin Univ Lozano Blesa, Zaragoza, Spain - Author
Hosp Clin Valencia, Valencia, Spain - Author
Hosp Donostia, San Sebastian, Spain - Author
Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain - Author
Hosp Gen Virgen Rocio, Seville, Spain - Author
Hosp San Pedro de Alcantara, Caceres, Spain - Author
Hosp Son Llatzer, Palma De Mallorca, Spain - Author
Hosp Univ 12 Octubre, Inst Invest 12 Octubre, CIBERONC, Madrid, Spain - Author
Hosp Univ Canarias, Santa Cruz De Tenerife, Spain - Author
Hosp Valle De Hebron, Barcelona, Spain - Author
Hospital Clinic I Provincial, Institu d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain - Author
Hospital Clínico de Valencia, Valencia, Spain - Author
Hospital Clinico San Carlos, Madrid, Spain - Author
Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain - Author
Hospital de Donostia, San Sebastian, Spain - Author
Hospital de Madrid Sanchinarro, Universidad CEU San Pablo, Madrid, Spain - Author
Hospital General Universitario Gregorio Marañón, Instituto de Investigacion Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain - Author
Hospital General Virgen del Rocío, Sevilla, Spain - Author
Hospital San Pedro de Alcantara, Cáceres, Spain - Author
Hospital Son Llatzer, Palma de Mallorca, Spain - Author
Hospital Universitario 12 de Octubre, Instituto de Investigación 12 de Octubre, CIBERONC, Madrid, Spain - Author
Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain - Author
Hospital Vall d'Hebrón, Barcelona, Spain - Author
Insitut Català d'Oncologia, Institut Josep Carreras, Hospital German Trias i Pujol, Badalona, Barcelona, Spain - Author
Inst Oncol Dr Josep Trueta, Girona, Spain - Author
Josep Trueta, Girona, Spain - Author
Preventive Medicine and Public Health Department, University of Navarra, Pamplona, Spain - Author
Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain - Author
Univ CEU San Pablo, Hosp Madrid Sanchinarro, Madrid, Spain - Author
Univ Murcia, IMIB Arrixaca, Hosp Univ Morales Meseguer, Serv Hematol & Oncol Med, Murcia, Spain - Author
Univ Navarra, Prevent Med & Publ Hlth Dept, Pamplona, Spain - Author
See more

Abstract

Following the publication of this article, the author notes that the following information was missed from the acknowledgments section.

Keywords

Responsible consumption and production

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Leukemia due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2019, it was in position 5/76, thus managing to position itself as a Q1 (Primer Cuartil), in the category Hematology. Notably, the journal is positioned above the 90th percentile.

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-08-07:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 6.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 7 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 0.25.
  • The number of mentions on the social network Facebook: 1 (Altmetric).
Continuing with the social impact of the work, it is important to emphasize that, due to its content, it can be assigned to the area of interest of ODS 12 - Ensure sustainable consumption and production patterns, with a probability of 50% according to the mBERT algorithm developed by Aurora University.